VEGFA and peripheral arterial disease: Computational models, based on mass-action kinetics of the signaling axis, have characterized VEGF–VEGFR binding in both healthy and diseased tissue [391, 392], VEGF spatial distribution in skeletal muscle [393–395], angiogenic sprouting in skeletal muscle [396, 397], and VEGF gradients in peripheral artery disease (PAD) [398].